Tag Archives: Heron Therapeutics

FDA Again Dings Heron’s Opioid Alternative Over “Nonclinical Issues”

Heron Therapeutics revealed Monday that its investigational non-opioid drug for treating postoperative pain has again been rejected by the FDA. The San Diego company’s HTX-011 is an extended-release solution of bupivacaine, a local anesthetic, and meloxicam, a nonsteroidal anti-inflammatory drug. Heron (NASDAQ: HRTX) positioned it as a pain management option that could contribute to a […]

Posted in National blog main, San Diego, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , | Comments Off on FDA Again Dings Heron’s Opioid Alternative Over “Nonclinical Issues”

Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More

The wait continues. An FDA ruling on a Duchenne muscular dystrophy drug from Sarepta Therapeutics—which could be the first ever approved for the disease—has been imminent for a while now, yet Labor Day is fast approaching and still the saga drags on. Speculation abounds, from analysts and pundits, each giving different opinions as to whether […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Detroit blog main, Indiana blog main, National, National blog main, National top stories, New York blog main, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, San Francisco top stories, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More

Heron Gains FDA Support For Nausea Drug After A Year Under Review

The decision that Heron Therapeutics has been waiting on for almost a year is finally in: The FDA has approved the Redwood City, CA-based company’s drug for nausea and vomiting associated with certain chemotherapy regimens. Heron (NASDAQ: HRTX) first submitted a new drug application for the treatment, granisetron (Sustol), to the FDA in September 2015. […]

Posted in National blog main, National top stories, San Francisco, San Francisco blog main, San Francisco top stories, Texas blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Heron Gains FDA Support For Nausea Drug After A Year Under Review